Clinical Trials Logo

Opioid-induced Constipation clinical trials

View clinical trials related to Opioid-induced Constipation.

Filter by:

NCT ID: NCT01957046 Completed - Clinical trials for Opioid Induced Constipation

A Single-arm, Study to Assess the Effect and Tolerability of Standardised Laxative Therapy (SLT) for the Reversal of Opioid-induced Constipation (OIC).

Start date: October 2013
Phase: Phase 4
Study type: Interventional

The main purpose of this study is to assess how effective and tolerable the country specific clinical practice guidelines of SLTs are for UK, France and Sweden are. The main rationale behind this study is that well controlled comparisons of the various laxatives for the treatment of OIC are lacking. There is lack of evidence suggesting which laxative or combination of laxatives is optimal for managing OIC.

NCT ID: NCT01901341 Terminated - Clinical trials for Opioid-Induced Constipation

The Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Start date: July 2, 2013
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of CB-5945 for the treatment of opioid-induced constipation (OIC) in adults taking opioid therapy for chronic non-cancer pain.

NCT ID: NCT01901328 Terminated - Clinical trials for Opioid-Induced Constipation

Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Start date: April 7, 2013
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of CB-5945 for the treatment of opioid-induced constipation (OIC)in adults taking opioid therapy for chronic non-cancer pain.

NCT ID: NCT01901302 Terminated - Clinical trials for Opioid-Induced Constipation

Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Start date: May 20, 2013
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of CB-5945 for the treatment of opioid-induced constipation (OIC) in adults taking opioid therapy for chronic non-cancer pain.

NCT ID: NCT01812733 Completed - Pain Clinical Trials

Non-interventional Study Comparing Targiniq and Oxycodone/Laxatives

Start date: June 2013
Phase: N/A
Study type: Observational

The objective of the non-interventional study is to compare the quality of life, health care resource use and costs between the use of a combination of oxycodone and naloxone (Targiniq) versus oxycodone and laxatives for patients with severe pain, and to evaluate the cost-effectiveness of treatment with Targiniq.

NCT ID: NCT01696643 Terminated - Clinical trials for Opioid-Induced Constipation

Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Start date: October 12, 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the long-term safety and tolerability of CB-5945 for the treatment of opioid-induced constipation (OIC) in adults taking opioid therapy for chronic non-cancer pain.

NCT ID: NCT01645371 Completed - Clinical trials for Opioid-induced Constipation

Assessing a Stool Symptom Screener in Patients With Chronic Opioid-Induced Constipation

Start date: August 2012
Phase: N/A
Study type: Observational

This qualitative research is to assess the validity of the stool symptom screener that will be used in patients with chronic opioid-induced constipation to determine the adequacy of their response to laxatives.

NCT ID: NCT01623609 Completed - Clinical trials for Opioid Induced Constipation

Open Label, Healthy Volunteers, Bioequivalence Study With Naloxegol

Start date: July 2012
Phase: Phase 1
Study type: Interventional

The purpose of this study is to demonstrate the Bioequivalence, assess food administration on the Pharmacokinetics with naloxegol.

NCT ID: NCT01459926 Completed - Clinical trials for Opioid Induced Constipation

A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of TD-1211 in Subjects With Opioid-Induced Constipation

Start date: November 2011
Phase: Phase 2
Study type: Interventional

A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of TD-1211 in Subjects with Opioid-Induced Constipation

NCT ID: NCT01443403 Completed - Clinical trials for Opioid Induced Constipation

A Study of S-297995 for the Treatment of Opioid-Induced Constipation in Subjects With Non-Malignant Chronic Pain Receiving Opioid Therapy

Start date: August 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine efficacy and safety of S-297995 for the treatment of opioid-induced constipation in subjects with non-malignant chronic pain receiving opioid therapy for ≥3 months